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I N T R O D U C T I O N
Fungal  metabolites  include  a  variety  of  indole  alka-
loids, among which are the most potent nonpeptidergic 
blockers of Ca
2+- and voltage-activated Slo1 (KCNMA1) 
large-conductance Ca
2+-activated K
+ (BK)-type K
+ channels 
yet identified. Such compounds, including paxilline, 
penitrem A (Cole and Cox, 1981; Knaus et al., 1994), 
and lolitrem B (Imlach et al., 2009) block Slo1 channels 
at nM concentrations. Although scorpion toxins such as 
iberiotoxin and charybdotoxin (CTX) can also inhibit 
Slo1 channels at nM concentrations (Giangiacomo et al., 
1992, 1993), Slo1 channels containing particular auxil-
iary  subunits exhibit resistance to block by such toxins 
(Xia et al., 1999; Meera et al., 2000; Xia et al., 2000). 
This renders the scorpion toxins less useful as tools for 
evaluating the role of Slo1 channels in native tissues. 
As a consequence, paxilline is increasingly used as a 
relatively potent and apparently relatively specific Slo1 
channel blocker (Shao et al., 1999; Raffaelli et al., 2004; 
Tammaro et al., 2004; Essin et al., 2009). The mecha-
nism and site of action of paxilline and other related 
compounds remain poorly understood. Block by paxil-
line has been proposed to involve an allosteric effect on 
Slo1 channel function (Sanchez and McManus, 1996). 
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Various fungal indole alkaloids are also able to allosteri-
cally regulate binding of CTX to Slo1 channels (Knaus 
et al., 1994). Interestingly, some compounds increase 
CTX binding and others inhibit it, although all share 
the ability to block BK channels. The allosteric effect 
of paxilline on CTX binding argues that paxilline does 
not bind to the CTX binding site, which is known to 
involve the extracellular turret of the Slo1 channel 
(Giangiacomo et al., 2008), but indirectly alters the 
CTX binding affinity.
Here, we have explored the structural elements of 
Slo1 channels that may be required for inhibition by 
paxilline. We find that the pH-regulated Slo3 K
+ chan-
nel, a homologue of Slo1, is resistant to blockade by 
paxilline, and through a set of Slo1/Slo3 chimeras iden-
tify Slo1 S6 as necessary for paxilline block. Mutational 
analysis reveals that a critical glycine residue (G311) in 
Slo1 is essential to maintain high affinity block by paxil-
line and can restore paxilline sensitivity in constructs 
containing a Slo3 S6 segment. We hypothesize that the 
presence or absence of G311 defines two distinct con-
formations of the S6 helix, either allowing or negating 
block by paxilline.
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The tremorogenic fungal metabolite, paxilline, is widely used as a potent and relatively specific blocker of Ca
2+- and 
voltage-activated Slo1 (or BK) K
+ channels. The pH-regulated Slo3 K
+ channel, a Slo1 homologue, is resistant to 
blockade by paxilline. Taking advantage of the marked differences in paxilline sensitivity and the homology be-
tween subunits, we have examined the paxilline sensitivity of a set of chimeric Slo1/Slo3 subunits. Paxilline sensi-
tivity is associated with elements of the S5–P loop–S6 module of the Slo1 channel. Replacement of the Slo1 S5 
segment or the second half of the P loop results in modest changes in paxilline sensitivity. Replacing the Slo1 S6 
segment with the Slo3 sequence abolishes paxilline sensitivity. An increase in paxilline affinity and changes in 
block kinetics also result from replacing the first part of the Slo1 P loop, the so-called turret, with Slo3 sequence. 
The Slo1 and Slo3 S6 segments differ at 10 residues. Slo1-G311S was found to markedly reduce paxilline block.   
In constructs with a Slo3 S6 segment, S300G restored paxilline block, but most effectively when paired with a Slo1 
P loop. Other S6 residues differing between Slo1 and Slo3 had little influence on paxilline block. The involvement 
of Slo1 G311 in paxilline sensitivity suggests that paxilline may occupy a position within the central cavity or access 
its blocking position through the central cavity. To explain the differences in paxilline sensitivity between Slo1 and 
Slo3, we propose that the G311/S300 position in Slo1 and Slo3 underlies a structural difference between subunits 
in the bend of S6, which influences the occupancy by paxilline.
© 2010 Zhou et al.  This article is distributed under the terms of an Attribution–Noncom-
mercial–Share Alike–No Mirror Sites license for the first six months after the publication 
date (see http://www.rupress.org/terms). After six months it is available under a Creative 
Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as de-
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y482 Paxilline block of BK channels
S5:
Slo1 235 LVNLLSIFISTWLTAAGFIHLVEN 258
Slo3 224 LSKLLSIVISTWFTAAGFLHLVEN 247
First half P loop (turret residues):
Slo1 259 SGDPWENFQNNQALTYWECVY 279
Slo3 248 SGDPWLNGRNSQTMSYFESIY 268
Second half of P loop (pore helix and selectivity filter):
Slo1 280 LLMVTMSTVGYGDVYAKTTL 299
Slo3 269 LVTATMSTVGFGDVVAKTSL 288
S6:
Slo1 300 GRLFMVFFILGGLAMFASYVPEIIELI 326
Slo3 289 GRIFIVFFTLGSLILFANTIPEMVELF 315
Many of the chimeras used in this study exhibit interesting gating 
behaviors, including shifts in activation gating, gating kinetics, 
and persistent current activation at negative voltages. Future study 
of such chimeras may prove useful in regards to investigation of 
allosteric regulation of this family of channels. However, here we 
are simply concerned with whether aspects of block by paxilline 
are retained or abolished.
Estimates of block affinity
The specific molecular mechanism of block by paxilline is not 
known. Here, to provide an estimate of relative paxilline sensitiv-
ity of different constructs, we assume that paxilline blocks both 
open and closed states, and that block of G-V curves is defined by 
block occurring at the holding potential. This assumption is based 
on the fact that both the rates of paxilline block onset and recov-
ery are slow relative to the duration of the voltage steps used to 
define block. Furthermore, there is no indication of any time-de-
pendent block or unblock during the voltage steps used to define 
BK conductance. Thus, block observed at any test potential is 
likely to be that observed during the holding potential condi-
tions. To describe activation, we used the allosteric model of BK 
channel activation (Horrigan and Aldrich, 2002) in which open 
probability (Po) is defined by three independent conformational 
equilibria: L (voltage dependence zL), J (voltage dependence zJ), 
and K, reflecting the channel closed–open equilibrium, the volt-
age sensor equilibrium, and the Ca
2+ binding constant, respec-
tively. D, C, and E correspond to constants for coupling between 
voltage sensor movement to channel activation (D), between Ca
2+ 
binding and channel activation (C), and between Ca
2+ binding 
and voltage sensor activation (E). Defining
  1/L
L
1+J+K+JKE
1+JD+KC+JDKCE
=
1 4 ( ) , 
channel Po as a function of voltage, Ca
2+ and paxilline concentra-
tion for a model that involves block of both open and closed states 
is given in Eq. 1:
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L
+
1
L
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K
+
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=
+
1
1
,    (1)
where Kbc and Kbo are blocking affinities of paxilline for closed 
and open channels, respectively.
Given that there appears to be no equilibration of the blocking 
equilibrium during test steps, the applicability of Eq. 1 also re-
quires that, at the holding potential, Kbc = Kbo, because otherwise 
Eq. 1 would predict some reequilibration in the steady-state G-V 
curves. In such a case, we define Kb = Kbc = Kbo.
Is it appropriate to use Eq. 1 for the set of constructs examined 
here, when the allosteric constants for each construct have not 
M AT E R I A L S   A N D   M E T H O D S
General methods
Oocyte preparation, handling of RNA, and electrophysiological 
methods used here were identical to those described in other re-
cent papers from this laboratory (Tang et al., 2009, 2010). All ex-
periments  used  excised  inside-out  patches  in  which  solution 
exchange at the pipette tip was accomplished with an SF-77B fast 
perfusion stepper system (Warner Instruments). Pipettes were 
typically 1–2 MΩ and were coated with Sylgard (Sylgard 184; Corn-
ing) before heat polishing. Gigaohm seals were formed while the 
oocytes were bathed in frog Ringer (in mM: 115 NaCl, 2.5 KCl, 1.8 
CaCl2, and 10 HEPES, pH 7.4). After patch excision, the pipette 
tip was moved into flowing test solutions. The pipette solution 
(bathing the extracellular membrane face) contained (in mM): 
140 K-methanesulfonate, 20 KOH, 10 HEPES, and 2 MgCl2, pH 7.0. 
The composition of the solution used to bathe the cytoplasmic 
face of the patch membrane was (in mM): 140 K-methanesul-
fonate, 20 KOH, and 10 HEPES, with pH adjusted to 7.0. For 0 
Ca
2+, the solution also contained 5 mM EGTA. For 10 µM Ca
2+, it 
contained 5 mM HEDTA, and for 100 or 300 µM Ca
2+, no Ca
2+ 
buffer was included. For 10 µM Ca
2+, the solution was titrated with 
a Ca methanesulfonate solution to obtain the desired Ca
2+ con-
centration (Zhang et al., 2001), as defined with a Ca
2+-sensitive 
electrode calibrated with commercial Ca
2+ solutions (WPI). Measure-
ments and fitting of current recordings was accomplished either 
with Clampfit (MDS Analytical Technologies) or with programs writ-
ten in this laboratory. Experiments were performed at room tem-
perature (22–25°C).
Steady-state  current  measurements  were  used  to  calculate 
conductances with the assumption of a 0-mV reversal potential. 
Conductances at each voltage and drug concentration for any 
given patch were normalized to the maximum conductance   
(G/Gmax) measured under any condition for that patch. Conduc-
tance–voltage (G-V) curves were then generated from the mean 
estimates for the set of patches. When the time course of blocker 
onset was examined, depolarizing test pulses of 3–20 ms were 
applied at frequencies of 0.2/s to 1/s among different patches. 
For constructs in which stronger depolarizations were required 
for more robust current activation, slower frequencies were used 
to minimize the possibility of patch destruction. The brief dura-
tion of the test steps (3–20 ms) produced no time-dependent 
changes in block (or unblock), so variation in stimulus frequen-
cies will not impact on the extent of block observed in these ex-
periments. For example, variations in stimulus frequency between   
1 and 0.2 Hz did not alter the time course or extent of block by 
paxilline of Slo1.
Constructs
The coding region of mSlo1 (GenBank accession no. NM_010610; 
provided by L. Salkoff, Washington University School of Medi-
cine, St. Louis, MO) was subcloned into the pXMX oocyte expres-
sion vector (Tang et al., 2009). The mSlo3 construct (Schreiber et al., 
1998) was also obtained from L. Salkoff with updated information 
regarding Slo3 given in GenBank accession number AF039213 
(Zhang et al., 2006a). The DN5 chimeric construct (also termed 
1P3C), in which the Slo1 cytosolic domain is replaced with the 
Slo3 cytosolic domain, has been described previously (Xia et al., 
2004). Slo1/Slo3 chimeric constructs were generated by standard 
overlapping PCR methods used in the laboratory and were com-
posed of the following: MC13: Slo11-182:Slo3171-end; MC2: Slo11-233:
Slo3223-314:Slo1326-end;  MC6:  Slo11-258:Slo3248-288:Slo1300-end;  MC8: 
Slo11-258:Slo3248-268:Slo1280-end;  MC10:  Slo11-299:Slo3289-314:Slo1326-end; 
MC18: Slo11-279:Slo3269-288:Slo1300-end.
The sequences of the segments evaluated in the S5–P loop–S6 
segment are:  Zhou et al. 483
were then defined through the best fit to the full set of G-V curves 
in the presence of paxilline. The fitting of functions to various 
datasets was done with a Levenberg-Marquardt nonlinear least-
squares fitting algorithm implemented within software developed 
within this laboratory.
From the application of Eq. 1, we obtain an estimate for block 
affinity along with the 90% confidence limits returned by the fit-
ting algorithm. For two constructs for which there is no overlap in 
the 90% confidence limit, there is a <10% likelihood that the ob-
served difference would occur by chance. For the constructs ex-
amined here, pairwise comparisons suggest statistically significant 
differences among most pairs we have examined, even when the 
estimated blocking affinities differ by less than twofold. Because 
of concern about the reliability of blocker affinity estimates, in 
addition to the estimates in Fig. 1 (Kb = 10.6 ± 0.5 nM), we have 
also  examined  paxilline  block  of  Slo1  for  three  other  sets  of 
patches: one set used to test whether paxilline produces gating 
shifts, another in which the experiments were all done in the 
presence of DTT, and another in which we tested the Ca
2+ depen-
dence of paxilline block. For these three cases, the paxilline esti-
mates for apparent block affinity were 22.0 ± 0.4 nM (100 nM 
paxilline alone; n = 4 patches), 13.6 ± 0.7 (50 nM paxilline alone; 
n = 7), and 5.6 ± 0.2 (10 and 100 nM paxilline; n = 5). In other 
cases, we have noted apparently weaker block by paxilline. Thus, 
estimates of blocking affinity among different datasets may vary 
appreciably, even though the confidence limits associated with 
any individual estimate are small. Such differences are likely influ-
enced by the challenges of working with a sticky blocking drug. 
For example, for experiments done over different periods of time, 
there may be differences in nominal drug concentration resulting 
from slight differences in drug preparation and delivery (see   
below). The binding of paxilline to various surfaces during prepa-
ration and delivery or differences in the average time between 
drug preparation and delivery to the set of patches might impact 
on the final effective concentrations. Because of the demonstrated 
variation in affinity estimates among sets of Slo1 patches, the   
focus of the present experiments is therefore primarily on large 
differences in paxilline affinity.
Molecular modeling
The structure of the BK channel S5–pore loop–S6 domain (Fig. 2 A) 
was generated based on homology modeling using Modeller 9v4 
(Sali and Blundell, 1993). The Kv 1.2 structure (Long et al., 2005) 
was used as a template because there are no residue gaps between 
the BK channels and Kv 1.2. The cartoon in Fig. 2 A was gener-
ated using UCSF Chimera (Pettersen et al., 2004). The paxilline 
space-filling model was generated and optimized using Chem3D 
Pro (version 3.5.1; CambridgeSoft).
Chemicals
Salts for solution preparation were obtained from Sigma-Aldrich. 
Paxilline was obtained from Sigma-Aldrich. A 10-mM paxilline 
stock solution was prepared in 100% DMSO, and a 0.5-mM stock 
solution of paxilline was in 50% DMSO and stored at 20°C. Pax-
illine solutions used for experiments were prepared the day of an 
experiment and only used up to 4 h. To minimize loss of paxil-
line by binding to plastic surfaces, preparation of solutions was 
done entirely with glass beakers and pipettes. Paxilline solutions 
were delivered to patches via a multi-barrel pipette, with a glass 
perfusion line with Teflon junctions connecting the glass syringe 
reservoir  to  the  delivery  pipette.  Even  with  glass  components, 
there appeared to be some loss of paxilline in the reservoir over 
several hours, presumably due to binding to surfaces. DMSO was 
present in the final solutions at 0.05% for 500 nM paxilline,   
the highest concentrations tested. The paxilline concentrations 
found to be effective in our hands are several-fold higher than 
those reported in the initial studies on paxilline action (Knaus et al., 
been defined? Because we only examine paxilline block for a 
single activation condition, the specific terms for activation are 
not critical in defining blocking constants, as long as the assump-
tion regarding saturating Po is reasonably valid. Here, for all con-
structs in which the pore domain largely arises from Slo1, we have 
constrained the fits such that the limiting Po at maximal activa-
tion is close to 1.0. In contrast, for MC13-S310G, we have assumed 
a Po at +300 mV of 0.35, appropriate for MC13 and Slo3 (Zhang 
et al., 2006b; Tang et al., 2010). In this case, the G-V curve was re-
normalized to a maximum value of 0.35 at +300 mV before appli-
cation of Eq. 1.
Because we are not concerned about the detailed mechanism of 
paxilline here, we simply use Eq. 1 as an empirical description of 
paxilline effectiveness. It should be noted that if, at the holding 
potential, most channels (for all constructs examined here) are in 
closed states and there is little block or unblock during test steps, 
the value of Kbo would not be well-defined by the G-V curves. As 
such, the estimates obtained from Eq. 1 most likely reflect primar-
ily estimates of closed-channel block under the holding condi-
tions. For all experiments shown in this paper, patches were held 
at 0 mV at the indicated ligand concentrations, with a brief 10-ms 
step to 140 mV before steps to more depolarized test potentials.
One other aspect of paxilline block should be mentioned. It 
has been previously reported that paxilline block is associated 
with a rightward shift in G-V curves, particularly at low paxilline 
concentrations (Sanchez and McManus, 1996). Such a behavior is 
inconsistent with Eq. 1 and is also seen in Fig. 1 C as paxilline is 
increased from 0 to 5 nM (but not with additional paxilline in-
creases). However, in tests using a single 100-nM paxilline con-
centration with full recovery after washout of paxilline, we have 
not seen this phenomenon. We therefore suspect it may arise 
from shifts in G-V curves unrelated to paxilline that can arise in 
some patches during long duration recordings. However, to assess 
how such a shift might impact on our estimates of block affinity, 
we also fit the G-V curves in two other ways. First, with the assump-
tion that the G-V shift is part of the action of paxilline and reflects 
a stronger affinity of paxilline for closed channels (but no intrin-
sic voltage dependence of binding to either state), fitting with Eq. 1 
yielded  a  closed-channel  block  affinity  that  was  3.1  ±  0.3  nM, 
whereas the open-channel block affinity was 13.8 ± 0.53 nM. In 
this case, Eq. 1 would only strictly be applicable if the currents re-
flect a steady-state condition (which we have already argued is 
most certainly not the case). In fact, to account for the weaker 
block with depolarization seen in the G-V curves, one would ex-
pect to see a time-dependent unblock; this is not seen in the cur-
rent traces, therefore arguing against a gating shift as being part 
of paxilline action. Second, assuming that the G-V curve shift re-
flects a 16-mV shift during the initial 15–30 min of recording, a fit 
of a state-independent model to the G-V curves obtained solely in 
the presence of paxilline yielded a block affinity of 12.0 ± 0.7 nM. 
These considerations indicate that, regardless of the assumptions 
regarding blocking model, the blocking affinity of paxilline on 
Slo1 is 10–15 nM when patches are held at 0 mV with 10 µM of 
cytosolic Ca
2+. Thus, for comparative purposes, regardless of how 
one treats those datasets that may exhibit shift, Eq. 1 with the as-
sumption that Kbo = Kbc provides a useful measure of apparent 
block affinity.
The details of the fitting procedure are as follows. First, in fits 
of control G-V curves in the absence of blocker, zL, zJ, and E were 
constrained to 0.3 e, 0.58 e, and 2.4, respectively, whereas C was 
generally constrained to 8 and D to 11 (Horrigan and Aldrich, 
2002). The best-fit values for L and J were then determined; how-
ever, based on confidence limits, these values are not strongly 
constrained by the data when only a single Ca
2+ concentration is 
used. To fit the G-V curves in the presence of blocker, terms for 
channel activation were then constrained to the best-fit values to 
the activation G-V alone, whereas parameters for blocking models 484 Paxilline block of BK channels
quential  application  of  increasing  concentrations  of 
paxilline, with the duration of application of each con-
centration being sufficient to reach an apparent steady-
state level of block (Fig. 1 B). After the application of 
100 nM paxilline, patches were washed in control saline 
to ensure that currents recovered to near control levels, 
although full recovery was difficult to achieve. The   
inhibitory effects of paxilline were determined by mea-
surement of steady-state current levels at different ac-
tivation voltages (Fig. 1 C). Qualitatively, in some sets 
of patches we have observed that paxilline produces   
a greater fractional block at more negative activation   
voltages (Fig. 1 C), consistent with a positive shift in the 
G-V curves in the presence of paxilline, as reported by 
Sanchez and McManus (1996). Similar to their results, 
we also observed that any apparent G-V shift saturated 
at paxilline concentrations well below those producing 
maximal block of outward current. This discrepancy be-
tween the gating shifts and the fractional block of BK 
current suggests that they may arise from unrelated 
mechanisms. Because Slo1 G-V curves generated from 
1994; Sanchez and McManus, 1996). However, the concentrations 
we have found effective are similar to results in other recent work 
(Imlach et al., 2008). Aflatrem was from a 3-mg sample provided 
by D. Covey (Washington University School of Medicine, St. Louis, 
MO) in 1996, and the nominal concentrations reported here as-
sume no degradation during that period. Aflatrem was made up 
as a 500-µM stock in 50% DMSO and used at nominally 10 nM 
(0.001% DMSO). Penitrem A and verruculogen were obtained 
from Alomone Laboratories, prepared as 1-mM stocks in 50% 
DMSO and used at 10 nM with 0.0005% DMSO.
R E S U LT S
Properties of block of macroscopic Slo1 currents  
by paxilline
The blockade of Slo1 channels by paxilline was studied 
in inside-out patches by examination of fractional block 
with different concentrations of paxilline at different acti-
vation voltages. The blocking effect of different paxilline 
concentrations at +120 mV on Slo1 currents activated 
with 10 µM Ca
2+ is shown in Fig. 1 A. The concentration 
dependence of paxilline block was determined by se-
Figure 1.  Paxilline blocks Slo1, but not Slo3 cur-
rent. (A) Traces show block of Slo1 by paxilline, and 
the general topology of the Slo1  subunit is shown 
on  the  top.  Currents  were  activated  by  a  step  to   
+120 mV in an inside-out patch exposed to 10 µM 
Ca
2+ with the indicated concentrations of paxilline. 
The holding potential was 0 mV, but the command 
steps were preceded by a brief 10-ms step to 140 mV.   
(B) The time course of paxilline block and unblock 
of Slo1 current is illustrated. Steps were to +100 mV. 
(C)  G-V  curves  were  generated  from  steady-state 
current  levels  for  recordings  in  the  absence  and 
presence of paxilline (n = 4–7 patches). For this set 
of data, paxilline was applied at increasing concen-
trations, and full washout was not usually achieved   
(see B). Red lines correspond to a fit of Eq. 1, with 
Kb = 10.6 ± 0.49 nM with zc = zo = 0 e. (D) 500 nM 
paxilline  is  without  effect  on  MC13  currents  acti-
vated at +200 mV with pH 8.5. The composition of 
the MC13 construct is schematized at the top with 
Slo3 sequence shown in red. (E) MC13 currents are 
unaltered by 500 nM paxilline during 6 min of ap-
plication. (F) 500 nM paxilline has little effect on 
MC13 G-V curves.  Zhou et al. 485
construct (MC2) were entirely resistant to block by 
500 nM paxilline (Fig. 3, A and B). When the Slo1 S5 
segment was replaced with the Slo3 sequence (MC28), 
blockade  by  50  nM  paxilline  was  retained  (Fig.  3,   
C and D). A fit of Eq. 1 with the assumption of state in-
dependence and no voltage dependence yielded a block-
ing constant of 30.4 ± 1.7 nM. In contrast, when the 
Slo1  S6  segment  was  replaced  by  the  Slo3  sequence 
(MC10), 100 nM paxilline had no effect (Fig. 3, E and F). 
This set of chimeras establishes that some feature of 
Slo1 S6, either specific residues or structure, is essential 
for blockade by paxilline.
The Slo1 pore helix also influences effectiveness of block 
by paxilline
Chimeras were also examined in which parts of the 
Slo1 pore loop were replaced with the Slo3 sequence.   
currents recorded in inside-out patches may show some 
positive shifts during the first 10 or 20 min of recording, 
we were concerned about the origins of the apparent   
G-V shift during the long times required to collect data 
in paxilline. In a separate set of four patches, we limited 
paxilline application to a single concentration of 100 nM. 
In this case, we observed an 8-mV average positive 
shift in the presence of paxilline, but this shift did not 
reverse with paxilline washout. We are therefore unable 
to conclude that paxilline is responsible for small posi-
tive shifts in the Slo1 G-V curves.
To provide an estimate of the blocking effectiveness 
of paxilline on Slo1 current, we fit the family of G-V 
curves to Eq. 1, assuming identical block of both open 
and  closed  channels,  as  described  in  Materials  and 
methods. This provides an apparent block affinity esti-
mate that can be used for comparison to other con-
structs. From Eq. 1, this yielded an estimate of paxilline 
block affinity of 10.6 ± 0.5 nM.
The pH-regulated Slo3 channel is resistant to blockade  
by paxilline
The pH-regulated Slo3 channel does not express ro-
bustly in Xenopus oocytes (Zhang et al., 2006a). To allow 
investigation of many aspects of Slo3 function without 
challenges of poor expression, we have created a Slo1/
Slo3 chimeric construct, termed MC13, which retains 
the characteristic functional properties of Slo3, includ-
ing pH and voltage dependence, single-channel prop-
erties,  and  gating  behavior  (Tang  et  al.,  2010).  This 
construct replaces S0, S1, S2, and part of S3 of Slo3 with 
homologous sequence from Slo1 (see Materials and 
methods). Replacement of S0 alone was insufficient to 
enhance Slo3 expression. MC13 currents were activated 
in inside-out patches with pH 8.5 and positive voltage 
steps (Fig. 1 D). MC13 currents were essentially insensi-
tive to 500 nM paxilline (Fig. 1, E and F). In other ex-
periments, 100 nM paxilline was without effect when 
applied for over 30 min. The lack of effect of 500 nM 
paxilline on MC13 indicates that Slo1 is at least three 
orders of magnitude more sensitive to paxilline.
Paxilline sensitivity is determined by elements  
within the S5–pore loop–S6 segments of Slo1
To assess potential determinants of paxilline block, we 
focused our attention on the portion of the Slo1 and 
Slo3 channels that contain the S5–pore loop–S6 seg-
ments (Fig. 2 A). Chimeric constructs were created in-
volving four segments within this region, S5, the first 
part of the pore loop, the second half of the pore loop, 
and then S6 (Table I and Fig. 2 A). Fig. 2 A also illus-
trates the relative size of a paxilline molecule compared 
with the Slo1 S5–S6 domain, whereas the chemical com-
position of paxilline is provided in Fig. 2 B.
When the entire S5–pore loop–S6 in Slo1 was re-
placed with the Slo3 sequence, currents from the resulting 
Figure 2.  S5–pore loop–S6 segments of the BK channel and the 
relative size of the paxilline molecule. (A) A homology model of 
the BK channel S5–pore loop–S6 structure was generated based 
on alignment with Kv1.2 and the available Kv1.2 crystal structure. 
Coloring identifies segments used for generation of chimeras as 
follows: red, S5; yellow, first half of pore loop; blue, second half 
of pore loop, including so-called turret; gray, S6. Orange residues   
are those that influence iberiotoxin binding (Giangiacomo et al.,   
2008). G311 in S6 is highlighted in magenta. A space-filling model 
of paxilline (to the same scale) is positioned adjacent to an S5   
helix, but this positioning is not meant to imply anything about 
the position of paxilline in a blocking site. Note that the actual 
topology of the BK turret is entirely unknown. Furthermore, this 
cartoon does not take into account the likely large width of the BK 
central cavity. (B) The chemical structure of paxilline is shown.486 Paxilline block of BK channels
for a slow-acting, sticky blocker like paxilline, we sought 
independent tests to see if altering the pore loop seg-
ment impacts on paxilline affinity. For MC8, the appar-
ently stronger paxilline block affinity is correlated with 
pronounced effects on blocking rates. The rate of onset 
of paxilline block for MC8 was clearly faster than for 
Slo1, even when MC8 was blocked with a fivefold lower 
concentration (Fig. 5, A and B). The effective forward 
rate of block for MC8 was 10-fold faster than for 
block of Slo1 (P < 0.0005; t test assuming equal vari-
ance) (Fig. 5 C). In contrast, recovery from paxilline 
block of MC8 was not statistically different from that for 
Slo1 (Fig. 5 B; P > 0.2). Assuming a simple first-order 
blocking reaction, with on = 1/(kon + koff) and off = 1/koff, 
effective  first-order  blocking  rates  and  blocking  con-
stants were calculated (Fig. 5 C). The forward rates of 
block were 0.13 × 10
6 M
1s
1 and 1.45 × 10
6 M
1s
1 for 
Slo1 and MC8, respectively. Blocking constants estimated 
from the rates were 48.8 ± 5.9 nM and 6.8 ± 1.6 nM for 
Slo1 and MC8, respectively. In contrast, if the steady-
state conductances for these same sets of patches were 
In construct MC6, in which the entire Slo1 pore loop was 
replaced with the Slo3 sequence, paxilline sensitivity only 
slightly reduced (two- to threefold) compared with wild-
type Slo1 (Fig. 4 A). The estimated blocking affinity of 
paxilline for MC6 assuming state-independent block was 
Kb = 23.2 ± 1.0 nM. When only the second half of the Slo1 
P loop (residues 280–299) was replaced with the Slo3 se-
quence (construct MC18), paxilline sensitivity was also 
reduced about threefold compared with Slo1 (for MC18, 
Kb = 30.0 ± 1.4) (Fig. 4 B). In contrast, when only the first 
half of the P loop was replaced with the Slo3 sequence 
(MC8), the paxilline block affinity was increased about 
twofold (Kb = 4.04 ± 0.10 nM) relative to Slo1 (Fig. 4 C). 
These results suggest that the composition of the pore 
helix may impact on the ability of paxilline to block BK 
channels, perhaps reflecting the ability of tremorogenic 
alkaloids including paxilline to influence CTX binding 
to smooth muscle BK channels (Knaus et al., 1994).
Because estimates of blocking affinity among differ-
ent constructs might be expected to vary on the order 
of up to two- to threefold (see Materials and methods) 
Figure 3.  Replacement of the Slo1 S6 segment with the Slo3 sequence abolishes sensitivity to paxilline. (A) Replacing the Slo1 S5–P 
loop–S6 segment with the homologous Slo3 sequence (chimera MC2) abolishes paxilline sensitivity. The MC2 construct is diagrammed 
at the top. Traces show MC2 currents activated with 10 µM Ca
2+ at +200 mV with and without 500 nM paxilline. (B) Paxilline has no effect 
on MC2 G-V curves (n = 4 patches). (C) Paxilline sensitivity persists after replacement of the Slo1 S5 segment with the homologous Slo3 
sequence. The MC28 construct is diagrammed at the top. Traces show MC28 currents activated with 10 µM Ca
2+ at +180 mV with and 
without paxilline. (D) G-V curves for MC28 with and without 50 nM paxilline (n = 3 patches) are shown. Red lines correspond to a fit 
of Eq. 1, with Kbc = Kbo = 30.4 ± 1.7 nM with no voltage dependence. (E) Paxilline sensitivity is lost when the Slo1 S6 segment is replaced 
with the homologous Slo3 sequence. The MC10 construct is diagrammed at the top. Traces show MC10 currents activated with 0 Ca
2+ at 
+200 mV with and without paxilline. MC10 is strongly activated by Ca
2+, but like Slo3 and MC13, it is also strongly blocked by µM Ca
2+. 
(F) G-V curves are shown for MC10 with and without paxilline (n = 4 patches).  Zhou et al. 487
tral cavity and perhaps the entrance to the cavity (Fig. 6 A). 
We created two sets of mutations. First, we mutated 
specific residues in Slo1 S6 to their corresponding Slo3 
residue to see whether paxilline sensitivity might be abol-
ished. Second, using the MC10 construct in which a Slo3 
S6 replaced the Slo1 S6 segment, we mutated selected 
non-conserved Slo3 residues to their Slo1 counterpart.
Slo1-G311S was found to completely abolish the abil-
ity of 500 nM paxilline to block currents (Fig. 6 B). Sim-
ilarly,  Slo1-G311A  was  also  completely  insensitive  to 
paxilline (Fig. 6 C). In contrast, Slo1-A313I (Fig. 6 D) 
and Slo1-M314L (Fig. 6 E) exhibited sensitivity to paxil-
line that was similar to native Slo1.
We next attempted to restore paxilline sensitivity to 
the MC10 construct. When residue S300 in MC10 was 
mutated to glycine (MC10-S300G), 50 nM paxilline pro-
duced strong block (Fig. 7 A) with an estimated Kb = 
13.1 ± 0.6 nM (Fig. 7 B), similar to block of wild-type 
Slo1. When S300G was substituted into MC13, paxilline 
sensitivity was also restored (Fig. 7 C), but it was less than 
fit with Eq. 1 based on the single concentration of paxil-
line tested in each case, the block affinities were 6.3 ± 
0.3 nM for Slo1 and 4.1 ± 0.1 for MC8. We have noted a 
similar discrepancy between the rate-based and equilib-
rium estimates of paxilline block of Slo1 in another set 
of seven patches, whereas any discrepancy is small for 
MC8. Although we have no definitive explanation why 
the rate-based estimate of paxilline block affinity of Slo1 
is much weaker than that estimated from the fit of the 
G-V curves, such a discrepancy might arise if the strict 
assumption  of  a  first-order  blocking  reaction  was  in-
valid.  For  present  purposes,  the  differences  between 
paxilline block of Slo1 and MC8 simply serve to point 
out that the Slo1 pore loop segment impacts on the 
properties of paxilline block.
A critical residue in Slo1 S6 is necessary and sufficient  
to permit block by paxilline
Slo1 and Slo3 differ in 10 residues along the portion of 
the S6 segment that is likely to contribute to the BK cen-
Figure 4.  The P loop segment modestly influences paxilline sensitivity. (A) Exchanging the Slo1 P loop with the homologous Slo3 
sequence (MC6) on paxilline sensitivity has little or weak effects on paxilline sensitivity. The MC6 construct is schematized on the top. 
Traces show the effect of various paxilline concentrations on MC6 currents evoked by a step to +200 mV with 10 µM Ca
2+. (B) G-V curves 
are plotted for MC6 with and without paxilline (n = 4–5 patches). The red lines correspond to the best fit of a model in which paxilline 
blocks both open and closed channels identically (Kb = 23.2 ± 1.0 nM) with no voltage dependence. (C) Replacing the second half of the 
Slo1 P loop with the homologous Slo3 sequence (MC18) has little effect paxilline sensitivity. The MC18 construct is diagrammed at the 
top. Traces show MC18 currents activated with 10 µM Ca
2+ at +180 mV with and without paxilline. (D) G-V curves are plotted for MC18 
with and without paxilline (n = 4 patches), with the red lines showing a fit of Eq. 2 with Kb = 30.0 ± 1.4 and z = 0 e. (E) Replacing the first 
half of the Slo1 P loop with the homologous Slo3 sequence (MC8) increases paxilline sensitivity. The MC8 construct is diagrammed at 
the top. Traces show MC8 currents activated with 10 µM Ca
2+ at +200 mV in the presence and absence of paxilline. (F) G-V curves are 
displayed for MC8 with and without paxilline (n = 5 patches). Red lines correspond to a fit of Eq. 1 with equivalent open- and closed-
channel block (Kb = 4.04 ± 0.10 nM) with no voltage dependence.488 Paxilline block of BK channels
that observed in wild-type Slo1, with Kb = 170.2 ± 7.2 nM 
(Fig. 7 D). In contrast, constructs MC10-M311I/V312I, 
MC10-N306S/I308V, and MC10-T297I were not blocked 
by 50 nM paxilline. These results again support the idea 
that the G311(Slo1)/S300(Slo3) position is the key de-
terminant that defines paxilline sensitivity of a construct. 
Furthermore, the differential ability of the S300G substi-
tution to restore paxilline sensitivity in MC10 and MC13 
provides further support for the idea that the pore loop 
can influence the paxilline block affinity.
Figure 5.  Replacing the first half of the Slo1 P loop with the Slo3 
sequence increases paxilline block affinity and speeds up paxil-
line block and unblock rates. (A) The time course of onset and 
recovery of paxilline block for Slo1 (black) and MC8 (red) is 
shown for representative inside-out patches for each construct. 
For MC8, 20 nM paxillline was applied (horizontal bar), and 100 nM   
was used for Slo1. Peak current activated at +200 mV was mea-
sured every 2 (Slo1) or 3 (MC8) seconds and plotted against time. 
(B) Time constants of onset of paxilline block (on) and recovery 
(off) are plotted for Slo1 (at 100 nM) and MC8 (at 20 nM). Red 
dots are individual determinations, and bars indicate means and 
SEM. (C) The forward block rate and paxilline block affinity were 
calculated for each individual patch for Slo1 and MC8. Block rate 
(left axis) and affinity (right axis) were determined from on = 
1/([PAX]kf+ku), ku = 1/off, and Kb = ku/kf.
Figure 6.  Mutation of glycine 311 in Slo1 S6 abolishes high af-
finity block by paxilline. (A) A consensus alignment of Slo1 and 
Slo3 S6 segments is shown. Non-conserved residues are in red. 
(B) Paxilline is without effect on Slo1-G311S. Currents were acti-
vated with 10 µM Ca
2+ at +200 mV, and 500 nM paxilline produces 
no effect. On the bottom, G-V curves for Slo1-G311S with and 
without 500 nM paxilline (n = 3 patches) are plotted. (C) Pax-
illine is without effects on Slo1-G311A. Currents were activated 
with 10 µM Ca
2+ at +200 mV, and 500 nM paxilline had only a 
minor effect. G-V curves plotted on the bottom also show lack of 
paxilline effect (n = 5 patches). (D) Paxilline sensitivity persists in 
Slo1-A313I. Currents activated with 100 µM Ca
2+ are blocked by 
20 and 100 nM paxilline, as also shown in the G-V curves on the 
bottom (n = 5 patches). (E) Paxilline blocks Slo1-M314L. Cur-
rents activated with 100 µM Ca
2+ are blocked in a concentration-
dependent fashion by paxilline, as summarized in the G-V curves 
on the bottom (n = 8 patches). Red line corresponds to fit with 
equivalent voltage-independent block of open and closed states 
with Kb = 13.3 ± 0.80 nM.  Zhou et al. 489
by  Slo3  sequence.  Activation  of  DN5  currents  is  en-
hanced by increases in cytosolic pH, and this construct 
does not respond to changes in cytosolic Ca
2+. We there-
fore examined the ability of paxilline to block DN5 cur-
rents during activation with pH 8.5 at various activation 
voltages (Fig. 8, C and D). DN5 was strongly blocked by 
paxilline with an effective Kb = 6.3 ± 0.3 nM. This sug-
gests that the ability of paxilline to block the Slo1 pore 
domain is neither sensitive to cytosolic pH nor to the 
nature of the cytosolic domain that is connected to the 
pore domain. We also compared block by 20 nM paxil-
line of MC10-S300G with either a cytosolic pH of 7.0   
Tests of other factors that might influence paxilline block
Residue G311 is adjacent to a second glycine residue, 
G310, which is conserved with Slo3 and most other volt-
age-dependent K
+ channels. To test whether G310 might 
act similarly in paxilline block, we created a Slo1-G310C 
construct. Paxilline effectively blocked Slo1-G310C (Fig. 8, 
A and B), although with a somewhat weaker blocking 
constant of 34.6 ± 1.8 nM than for wild-type alone. This 
supports the idea that G311 plays a unique role in per-
mitting paxilline block of Slo1.
We showed above that, although S300G restored pax-
illine sensitivity to MC13, MC13-S300G was much less 
sensitive to paxilline than MC10-S300G. Because MC13 
was studied with a cytosolic pH of 8.5, whereas MC10-
S300G was examined with a cytosolic pH of 7.0, we 
wished to determine whether pH might also influence 
block by paxilline. We used a construct termed DN5 
(also termed 1P3C in previous work; Xia et al., 2004), in 
which the complete Slo1 cytosolic domain is replaced 
Figure  7.  Paxilline  sensitivity  is  restored  in  constructs  with  a 
Slo3 S6 by a glycine at position S300. (A) Paxilline blocks MC10-
S300G. 50 nM paxilline markedly inhibits MC10-S300G currents 
activated at +150 mV with 0 Ca
2+. (B) G-V curves are plotted for 
MC10-S300G with and without 50 nM paxilline (n = 4 patches). 
Red lines are a fit of Eq. 2 with Kb = 13.1 ± 0.6 nM and no volt-
age dependence. (C) Paxilline more weakly blocks MC13-S300G. 
Traces show MC13-S300G currents activated at pH 8.5 at +200 mV. 
Inhibition occurs with high concentrations of paxilline. (D) G-V   
curves are plotted for MC13-S300G with and without paxilline   
(n = 3 patches). Red lines are a fit of Eq. 2 with Kb = 170.2 ± 7.2 nM   
and no voltage dependence.
Figure 8.  Other tests of factors influencing paxilline block.   
(A) Paxilline blocks construct Slo1-G310C. Traces show reduction of 
Slo1-G310C currents by the indicated paxilline concentrations with 
10 µM of cytosolic Ca
2+ and steps to +200 mV. (B) G-V curves are 
shown for paxilline block of Slo1-G310C. Red line corresponds 
to fit of voltage-independent block of open and closed states with   
Kb = 34.6 ± 1.8 nM. (C) Paxilline blocks DN5. Traces show paxilline 
block of DN5 in which the Slo1 cytosolic structure is replaced by 
Slo3. Currents were activated with cytosolic pH 8.5 with steps to 
+280 mV. (D) G-V curves are shown for paxilline block of DN5. 
Red lines show a fit with Kb = 6.3 ± 0.3 nM with z = 0 e. (E) Paxil-
line block on MC10-S300G G-V curves is similar at either pH 7.0 
(black) or pH 8.5 (red). In both cases, 20 nM paxilline produces 
similar block. (F) Points plot the peak current during the applica-
tion of 100 nM paxilline applied to outside-out patches expressing 
either Slo1 (black) or Slo1-G311S (red). Currents were activated 
by steps to +200 mV with 10 µM of pipette Ca
2+ with a holding 
potential of 0 mV.490 Paxilline block of BK channels
pletely blocked BK current (Fig. 9, A and B), while hav-
ing no effect on Slo1-G311S (Fig. 9, C and D). The 
blocking effects of penitrem A (Fig. 9, E–H) and ver-
ruculogen (Fig. 9, I–L) were also completely ablated by 
the G311S mutation. Thus, despite the differences in 
dimensions of each of these alkaloids, these blocking 
effects are all sensitive to the change in S6 produced by 
G311 mutation. 10 nM of either aflatrem, penitrem A, 
or verruculogen blocked BK channels more effectively 
than 10 nM paxilline. However, at 10 nM, the onset of 
block of each compound was similar, whereas washout 
times for aflatrem, penitrem A, and verruculogen were 
markedly slower than for paxilline.
D I S C U S S I O N
Based on a pronounced difference in paxilline sensitiv-
ity between Slo1 and Slo3, we have used a chimeric ap-
proach  that  defined  the  Slo1  S6  segment  as  the  key 
element required for blockade by paxilline. Subsequent 
or 8.5 (Fig. 8 E). Block by paxilline was indistinguish-
able in each case.
Finally, because paxilline is often applied extracellu-
larly to multicellular preparations, we examined the abil-
ity of paxilline to block either Slo1 or Slo1-G311S when 
applied to outside-out patches (Fig. 8 F). In this case, 
100 nM paxilline completely blocked Slo1 current, al-
though with a slower onset of block compared with ap-
plication to inside-out patches. In contrast, 100 nM 
paxilline was without effect on Slo1-G311S, even after 
nearly 20 min of application. Thus, regardless of the 
side of paxilline application, it is sensitive to mutation 
of G311.
Mutation of G311 also abolishes the BK blocking action  
of other fungal alkaloids
We also examined whether the ability of three other 
fungal alkaloids, aflatrem, penitrem A, and verruculo-
gen, to block BK channels (Knaus et al., 1994) was also 
sensitive to the G311S mutation. 10 nM aflatrem com-
Figure 9.  Block of BK channels by other fungal alkaloids is also abolished by the G311S mutation. (A) A Slo1 G-V curve for activation 
with 10 µM Ca
2+ is plotted for currents measured in the absence and presence of 10 nM aflatrem (n = 4 patches). (B) The time course 
of block by 10 nM aflatrem is shown for one patch. (C) 10 nM aflatrem is without effect on the G-V elicited by 10 µM Ca
2+ for the Slo1-
G311S construct. (D) Over 4 min of application of 10 nM aflatrem produces no reduction in current of Slo1-G311S. (E) The effect of 10 nM 
penitrem A on the Slo1 G-V curve is plotted. (F) The time course of block of Slo1 by penitrem A is plotted. (G) 10 nM penitrem A is 
without effect on Slo1-G311S conductance. (H) Over 5 min of application of 10 nM penitrem A has no effect on Slo1-G311S current.   
(I) Block of the Slo1 G-V by 10 nM verruculogen is plotted. (J) The time course of verruculogen block is displayed. (K) 10 nM verruculo-
gen is without effect on Slo1-G311S conductance. (L) Over 5 min of verruculogen application is without effect on Slo1-G311S current.  Zhou et al. 491
of  paxilline action. Here, we discuss two issues: first, 
possible implications of the ability of the single glycine 
residue to influence paxilline block and, second, im-
plications of these results concerning possible sites of 
paxilline action.
The critical role of G311
The chemical nature of glycine tends to preclude its in-
volvement in any direct interactions with paxilline. A 
more likely explanation is that mutation of G311 alters 
the shape or flexibility of the Slo1 S6 in such a way that 
prevents paxilline from occupying a site that either di-
rectly or indirectly produces current block. Glycine is 
well-known to allow bending or confer flexibility in an 
otherwise -helical segment, and the BK channel is un-
usual in having a pair of sequential glycines at positions 
310 and 311. This most certainly would allow for break-
ing of the hydrogen bonding that maintains an -heli-
cal structure. Interestingly, however, we found that the 
G310C and G310S mutations produce either small or 
no effect on paxilline block, indicating that the role of 
G311 is somehow unique in defining the S6 topology 
that is critical for paxilline block. A change in S6 topol-
ogy with mutation of G311 might alter block either   
by producing a steric hindrance that prevents paxilline 
from reaching its blocking position, or by resulting   
in changes in distance between multiple paxilline inter-
action points. Recent work suggests that the BK channel 
central cavity may be unusual among voltage-dependent 
K
+ channels in having a much wider central cavity (Brelidze 
and Magleby, 2005), and that this central cavity may be 
examination of residues not conserved between Slo1 
and Slo3 revealed that mutation of a single glycine resi-
due, G311, in Slo1 S6 completely abolishes paxilline 
block. Furthermore, replacement in Slo3 S6 of the ho-
mologous S300 with glycine at least partially restores 
paxilline block. In contrast, other S6 residues not con-
served between Slo1 and Slo3 had small effects or no 
substantial effect on paxilline sensitivity. The ability of 
mutation of a single glycine residue to abolish paxilline 
sensitivity is quite remarkable, particularly because gly-
cine is unlikely to participate directly in any binding 
interactions with paxilline. The effect of the G311 mu-
tation seems to point to an important structural differ-
ence between the S6 topology in Slo1 and Slo3 that may 
underlie the differential paxilline sensitivity.
Estimates of paxilline block affinity for various con-
structs, grouped into order of affinity, are summarized 
in Table I. We note that Slo1 shares a similar apparent 
affinity to DN5, Slo1-M314L, and MC10-S300G. That 
the stronger block affinity for MC8 reflects a real differ-
ence is given independent support by the changes in 
paxilline block rates on MC8 relative to Slo1. Constructs 
MC6, MC18, MC28, and Slo1-G310C all exhibit some-
what similar paxilline block affinities. However, because 
these estimates overlap to some extent with estimates 
for paxilline block of Slo1 that we have observed in 
some sets of patches (see Materials and methods), their 
paxilline sensitivity cannot be considered conclusively 
different from Slo1. Our results do not provide a mo-
lecular explanation for the paxilline block mechanism 
and do not allow firm conclusions regarding the site 
TA B L e   I
Summary of S5–pore loop–S6 chimeric constructs.
Construct S5............turret–pore helix–filter............S6 Kb
nM
Slo1 10.6 ± 0.5
MC8 4.04 ± 0.1
DN5 6.3 ± 0.3
Slo1 M314L 13.3 ± 0.8
MC10-S300G 13.1 ± 0.6
MC6 23.2 ± 1.0
MC18 30.0 ± 1.4
MC28 30.4 ± 1.7
Slo1 G310C 34.6 ± 1.8
MC13-S300G 170.2 ± 7.2
MC10 >>100
Slo1-G311S >>500
MC2 >>500
MC13 >>500492 Paxilline block of BK channels
site. Second, the S300G mutation in MC10 and MC13 
did not have identical effects on restoring paxilline sen-
sitivity, suggesting that pore loop differences between 
MC10 and MC13 alter the ability of paxilline to block. 
These results may relate to earlier studies in which pax-
illine block was observed to allosterically influence the 
binding of scorpion toxins to BK channels (Knaus et al., 
1994).  Interestingly,  different  tremorogenic  alkaloids 
were able to either up- or down-regulate CTX binding. 
Because the turret segment of the BK channel is inti-
mately involved in iberiotoxin binding (Giangiacomo 
et al., 2008), these earlier results are consistent with our 
data in supporting the idea that paxilline binding both 
influences the turret structure and, in turn, the turret 
structure influences paxilline block. Fig. 2 A highlights 
those residues in the extracellular part of the BK pore 
that are thought to influence iberiotoxin binding.
The ability of an S6 mutation to influence paxilline 
block might be interpreted to suggest that paxilline binds 
within the central cavity or gains access to its blocking 
position by entry through the central cavity. Although the 
large size of paxilline (Fig. 2 A) would seem to argue 
against the idea that the lipophilic paxilline molecule   
is able to intercalate into a position between helices, 
this possibility cannot be totally excluded at present. 
G311 may be essential for exposing the pathway to reach 
the appropriate blocking position. In such a case, inter-
calation might be imagined to influence the pore helix, 
thereby modifying block by extracellular scorpion toxin. 
One aspect of paxilline block that does seem unusual in 
comparison to other standard cytosolic pore blockers is 
the slow onset and recovery from paxilline block. Block 
by simple occlusion within the central cavity is presum-
ably  mediated  by  direct  exchange  with  the  cytosolic 
aqueous milieu and, even for an uncharged blocking 
molecule, that block should occur in accordance with 
simple diffusion. Our comparison of the blocking kinet-
ics of paxilline on Slo1 and MC8 indicates that, assum-
ing a first-order blocking process, the paxilline block 
rate of Slo1 is 0.15 × 10
6 M
1 s
1, whereas for MC8 we 
calculated a rate of 1.4 × 10
6 M
1s
1. This difference 
in paxilline block rates is unlikely to arise from differ-
ences in state occupancy at the holding potential be-
cause the Vh for activation of conductance with 10 µM 
Ca
2+ is essentially identical for Slo1 and MC8. Although 
the rate of block of MC8 begins to approximate that 
seen  for  diffusionally  controlled  reactions  for  larger 
molecules, the rate of paxilline block for Slo1 seems 
slower than one would expect for a simple pore occu-
pancy model. Furthermore, that this rate is altered by 
swapping the Slo1 turret segment with Slo3 turret se-
quence seems surprising, particularly because the un-
derlying  gating  equilibria  for  Slo1  and  MC8  are  so 
similar. Although these considerations cannot be con-
sidered to rigorously exclude a simple central cavity oc-
cupancy basis for paxilline block, both the slow rate of 
accessed even when the channel is in closed conforma-
tions (Wilkens and Aldrich, 2006; Tang et al., 2009).   
We imagine that the dimension of the central cavity, at 
least at some positions along the channel axis, may   
be related to the pair of sequential glycines found in   
BK channels.
It is also interesting that the glycine at position 311 in 
BK channels is shared with a large number of other volt-
age-gated K
+ channels, both eukaryotic and prokaryotic 
(Magidovich and Yifrach, 2004). Based on the ability of 
mutations at this position to alter the closed–open gat-
ing equilibrium, this glycine has been termed a gating 
hinge (Yifrach and MacKinnon, 2002; Magidovich and 
Yifrach, 2004) that influences the energetics of confor-
mational movements of S6 during the closed-to-open 
conformational change. Furthermore, it is at the level 
of the glycine hinge that the S6 helix in the structure of 
the open MthK channel exhibits a bend (Jiang et al., 
2002a,b). Interestingly, Slo3 is one of few K
+ channels 
that does not have a glycine at this precise position, al-
though it does have a glycine at Slo3 position 299, in 
alignment with Slo1-G310. Although in some K
+ chan-
nels mutation of the hinge glycine results in loss of cur-
rents, in BK channels, the G310A and G311A mutations 
each result in an 60-mV positive shift in G-V curves at 
a given Ca
2+, whereas the double mutation shifts gating 
120 mV (Yifrach and MacKinnon, 2002). Although 
these considerations do not impact directly on the in-
terpretation of the effects of paxilline, they do suggest 
that G311 may play a role in conformational changes 
occurring in S6 during BK gating, perhaps contributing 
to some unique bend or twist in the BK S6 that distin-
guishes it from other K
+ channels.
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fect the ability of paxilline to reach and leave its binding   Zhou et al. 493
charybdotoxin-iberiotoxin chimeric peptides define toxin bind-
ing sites on calcium-activated and voltage-dependent potassium 
channels. Biochemistry. 32:2363–2370. doi:10.1021/bi00060a030
Giangiacomo,  K.M.,  J.  Becker,  C.  Garsky,  W.  Schmalhofer,  M.L. 
Garcia, and T.J. Mullmann. 2008. Novel alpha-KTx sites in the BK 
channel and comparative sequence analysis reveal distinguish-
ing features of the BK and KV channel outer pore. Cell Biochem. 
Biophys. 52:47–58. doi:10.1007/s12013-008-9026-3
Horrigan, F.T., and R.W. Aldrich. 2002. Coupling between voltage 
sensor activation, Ca
2+ binding and channel opening in large con-
ductance (BK) potassium channels. J. Gen. Physiol. 120:267–305. 
doi:10.1085/jgp.20028605
Imlach, W.L., S.C. Finch, J. Dunlop, A.L. Meredith, R.W. Aldrich, 
and J.E. Dalziel. 2008. The molecular mechanism of “ryegrass 
staggers,” a neurological disorder of K
+ channels. J. Pharmacol. 
Exp. Ther. 327:657–664. doi:10.1124/jpet.108.143933
Imlach, W.L., S.C. Finch, J. Dunlop, and J.E. Dalziel. 2009. Structural 
determinants  of  lolitrems  for  inhibition  of  BK  large  conduc-
tance  Ca
2+-activated  K
+  channels.  Eur.  J.  Pharmacol.  605:36–45. 
doi:10.1016/j.ejphar.2008.12.031
Jiang, Y., A. Lee, J. Chen, M. Cadene, B.T. Chait, and R. MacKinnon. 
2002a. Crystal structure and mechanism of a calcium-gated potas-
sium channel. Nature. 417:515–522. doi:10.1038/417515a
Jiang, Y., A. Lee, J. Chen, M. Cadene, B.T. Chait, and R. MacKinnon. 
2002b.  The  open  pore  conformation  of  potassium  channels. 
Nature. 417:523–526. doi:10.1038/417523a
Knaus,  H.G.,  O.B.  McManus,  S.H.  Lee,  W.A.  Schmalhofer,  M. 
Garcia-Calvo,  L.M.  Helms,  M.  Sanchez,  K.  Giangiacomo,  J.P. 
Reuben, A.B. Smith III, et al. 1994. Tremorgenic indole alkaloids 
potently  inhibit  smooth  muscle  high-conductance  calcium-
activated  potassium  channels.  Biochemistry.  33:5819–5828. 
doi:10.1021/bi00185a021
Long, S.B., E.B. Campbell, and R. Mackinnon. 2005. Crystal struc-
ture of a mammalian voltage-dependent Shaker family K
+ chan-
nel. Science. 309:897–903. doi:10.1126/science.1116269
Magidovich,  E.,  and  O.  Yifrach.  2004.  Conserved  gating  hinge 
in  ligand-  and  voltage-dependent  K+  channels.  Biochemistry. 
43:13242–13247. doi:10.1021/bi048377v
Mayland,  H.,  P.  Cheeke,  W.  Majak,  and  J.  Goff.  2007.  Forage- 
induced animal disorders. In Forages: The Science of Grassland 
Agriculture. R. Barnes, C. Nelson, K. Moore, and M. Collins, edi-
tors. Blackwell Publishing, Aimes, IA. 687–707.
Meera, P., M. Wallner, and L. Toro. 2000. A neuronal beta subunit 
(KCNMB4) makes the large conductance, voltage- and Ca
2+-acti-
vated K
+ channel resistant to charybdotoxin and iberiotoxin. Proc. 
Natl. Acad. Sci. USA. 97:5562–5567. doi:10.1073/pnas.100118597
Miles, C.O., M.E. di Menna, S.W. Jacobs, I. Garthwaite, G.A. Lane, 
R.A.  Prestidge,  S.L.  Marshall,  H.H.  Wilkinson,  C.L.  Schardl, 
O.J. Ball, and G.C. Latch. 1998. Endophytic fungi in indigenous 
Australasian  grasses  associated  with  toxicity  to  livestock.  Appl. 
Environ. Microbiol. 64:601–606.
Pettersen,  E.F.,  T.D.  Goddard,  C.C.  Huang,  G.S.  Couch,  D.M. 
Greenblatt, E.C. Meng, and T.E. Ferrin. 2004. UCSF Chimera—a 
visualization  system  for  exploratory  research  and  analysis.  J. 
Comput. Chem. 25:1605–1612.
Raffaelli, G., C. Saviane, M.H. Mohajerani, P. Pedarzani, and E. 
Cherubini.  2004.  BK  potassium  channels  control  transmitter 
release at CA3-CA3 synapses in the rat hippocampus. J. Physiol. 
557:147–157. doi:10.1113/jphysiol.2004.062661
Sali, A., and T.L. Blundell. 1993. Comparative protein modelling by 
satisfaction of spatial restraints. J. Mol. Biol. 234:779–815.
Sanchez, M., and O.B. McManus. 1996. Paxilline inhibition of 
the  alpha-subunit  of  the  high-conductance  calcium-activated   
potassium  channel.  Neuropharmacology.  35:963–968.  doi:10.1016/ 
0028-3908(96)00137-2
block and the ability of the turret segment to influence 
this rate would be highly unusual features of a strictly 
simple central cavity occupancy mechanism.
Agricultural problems arising from fungal  
tremorogenic alkaloids
The compounds examined here are part of a family of 
fungal alkaloids endemic to range grasses that cause 
motor disturbances in livestock after ingestion (Miles 
et al., 1998; Mayland et al., 2007), and block of BK chan-
nels has been implicated as the molecular target under-
lying the tremorogenic effects of these alkaloids (Dalziel 
et al., 2005; Imlach et al., 2008). We note that the ability 
of a single point mutation to abolish block of several of 
these alkaloids raises the possibility that alkaloid sensi-
tivity of livestock could be genetically ablated. Because 
mutation of G311 is also associated with shifts in G-V 
curves, this strategy would also require a compensatory 
mutation, presumably in S6, that produces a normally 
functioning but toxin-resistant subunit. If such a sub-
unit could be designed, it would result in a physiologi-
cally normal animal, resistant to the motor disturbances 
of the alkaloids.
Summary
We have established that a single amino acid in Slo1 S6, 
G311, is the key determinant of the ability of paxilline 
to block BK channels. G311 appears likely to alter struc-
tural features of the Slo1 S6 helix that are permissive for 
paxilline block.
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